Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Restructures Business Units After Six-Month Market Study

NEW YORK, July 12 (GenomeWeb News) - Sigma-Aldrich will restructure its two life science and research businesses in an attempt to tap into its customer base more efficiently, the company said today.

 

The organization will divide Sigma's existing scientific research and biotechnology businesses into three "customer-centric" units. Each unit will be overseen by a president, reporting to the company's president and chief operating officer.

 

The firm's SAFC business will not be affected, the company said.

 

Sigma said it took the steps, which take effect immediately, after a six-month market study. Sigma president and COO Jai Nagarkatti said the reorganization "should enable us to ... deliver 10 percent top and bottom line growth long-term."

 

The new business units will be:

  • Essentials, which represents 20 percent of the company's current sales, will offer "account management to largely economic buyers" in pharmaceutical, academic, and other commercial research organizations. Gilles Cottier, vice president of sales at Sigma, will head the unit.
  • Specialties, which represents 35 percent of the company's current sales, will sell Sigma's products through its web site and catalogs to lab scientists. David Julien, most recently president of Sigma's biotechnology business, will run this business.
  • Biotech, which represents 20 percent of the company's current sales, will sell certain research tools for life scientists. This group will be headed by Shaf Yousaf, most recently vice president of corporate R&D and biotech marketing.

SAFC, represents 25 percent of Sigma's sales after the recent acquisition of JRH Biosciences, will sell fine chemical products and services. This unit "stands separate" from the other three. SAFC will continue to be led by Frank Wicks, who has served as the unit's president since January 2003.

Sigma said it plans to continue reporting sales results for the three existing scientific research, biotechnology, and SAFC units through 2005 and begin reporting under the new four-unit structure in 2006.

Additional details were not disclosed.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.